NCT00066430View on ClinicalTrials.gov

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2004

Study Completion Date

April 30, 2006

Conditions
Anal CancerPrecancerous Condition
Interventions
PROCEDURE

infrared photocoagulation therapy

DEVICE

Infrared Coagulator

IRC treatment of up to 3 HGAIN lesions at baseline (study initiation). A second IRC treatment may be administered for recurrent lesions at the 3 month visit.

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

94143

UCSF Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

AIDS Malignancy Consortium

NETWORK

NCT00066430 - Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | Biotech Hunter | Biotech Hunter